2.4.0.8 Html 84 222 1 false 33 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.tgtherapeuticsinc.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 103 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets [Parenthetical] false false R4.htm 104 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations false false R5.htm 105 - Statement - Condensed Consolidated Statement of Equity Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedStatementOfEquity Condensed Consolidated Statement of Equity false false R6.htm 106 - Statement - Condensed Consolidated Statement of Equity [Parenthetical] Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedStatementOfEquityParenthetical Condensed Consolidated Statement of Equity [Parenthetical] false false R7.htm 107 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.tgtherapeuticsinc.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows false false R8.htm 108 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.tgtherapeuticsinc.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 109 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://www.tgtherapeuticsinc.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS false false R10.htm 110 - Disclosure - INVESTMENT SECURITIES Sheet http://www.tgtherapeuticsinc.com/role/InvestmentSecurities INVESTMENT SECURITIES false false R11.htm 111 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.tgtherapeuticsinc.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS false false R12.htm 112 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R13.htm 113 - Disclosure - NOTES PAYABLE Notes http://www.tgtherapeuticsinc.com/role/NotesPayable NOTES PAYABLE false false R14.htm 114 - Disclosure - LICENSE AGREEMENTS Sheet http://www.tgtherapeuticsinc.com/role/LicenseAgreements LICENSE AGREEMENTS false false R15.htm 115 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.tgtherapeuticsinc.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R16.htm 116 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.tgtherapeuticsinc.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R17.htm 117 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.tgtherapeuticsinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R18.htm 118 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Sheet http://www.tgtherapeuticsinc.com/role/CashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS (Tables) false false R19.htm 119 - Disclosure - INVESTMENT SECURITIES (Tables) Sheet http://www.tgtherapeuticsinc.com/role/InvestmentSecuritiesTables INVESTMENT SECURITIES (Tables) false false R20.htm 120 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.tgtherapeuticsinc.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) false false R21.htm 121 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) false false R22.htm 122 - Disclosure - NOTES PAYABLE (Tables) Notes http://www.tgtherapeuticsinc.com/role/NotesPayableTables NOTES PAYABLE (Tables) false false R23.htm 123 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsTextual ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) false false R24.htm 124 - Disclosure - CASH AND CASH EQUIVALENTS (Details) Sheet http://www.tgtherapeuticsinc.com/role/CashAndCashEquivalentsDetails CASH AND CASH EQUIVALENTS (Details) false false R25.htm 125 - Disclosure - INVESTMENT SECURITIES (Details) Sheet http://www.tgtherapeuticsinc.com/role/InvestmentSecuritiesDetails INVESTMENT SECURITIES (Details) false false R26.htm 126 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://www.tgtherapeuticsinc.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) false false R27.htm 127 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1) Sheet http://www.tgtherapeuticsinc.com/role/FairValueMeasurementsDetails1 FAIR VALUE MEASUREMENTS (Details 1) false false R28.htm 128 - Disclosure - FAIR VALUE MEASUREMENTS (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/FairValueMeasurementsDetailsTextual FAIR VALUE MEASUREMENTS (Details Textual) false false R29.htm 129 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) false false R30.htm 130 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityDetails1 STOCKHOLDERS' EQUITY (Details 1) false false R31.htm 131 - Disclosure - STOCKHOLDERS' EQUITY (Details 2) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityDetails2 STOCKHOLDERS' EQUITY (Details 2) false false R32.htm 132 - Disclosure - STOCKHOLDERS' EQUITY (Details 3) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityDetails3 STOCKHOLDERS' EQUITY (Details 3) false false R33.htm 133 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/StockholdersEquityDetailsTextual STOCKHOLDERS' EQUITY (Details Textual) false false R34.htm 134 - Disclosure - NOTES PAYABLE (Details) Notes http://www.tgtherapeuticsinc.com/role/NotesPayableDetails NOTES PAYABLE (Details) false false R35.htm 135 - Disclosure - NOTES PAYABLE (Details Textual) Notes http://www.tgtherapeuticsinc.com/role/NotesPayableDetailsTextual NOTES PAYABLE (Details Textual) false false R36.htm 136 - Disclosure - LICENSE AGREEMENTS (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/LicenseAgreementsDetailsTextual LICENSE AGREEMENTS (Details Textual) false false R37.htm 137 - Disclosure - RELATED PARTY TRANSACTIONS (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/RelatedPartyTransactionsDetailsTextual RELATED PARTY TRANSACTIONS (Details Textual) false false R38.htm 138 - Disclosure - SUBSEQUENT EVENTS (Details Textual) Sheet http://www.tgtherapeuticsinc.com/role/SubsequentEventsDetailsTextual SUBSEQUENT EVENTS (Details Textual) false false All Reports Book All Reports Element tgtx_RoyaltyPaymentEffectivePercentage had a mix of decimals attribute values: 2 3. 'Monetary' elements on report '133 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] Process Flow-Through: 104 - Statement - Condensed Consolidated Statements of Operations Process Flow-Through: 106 - Statement - Condensed Consolidated Statement of Equity [Parenthetical] Process Flow-Through: 107 - Statement - Condensed Consolidated Statements of Cash Flows tgtx-20140630.xml tgtx-20140630.xsd tgtx-20140630_cal.xml tgtx-20140630_def.xml tgtx-20140630_lab.xml tgtx-20140630_pre.xml true true